Jessica Trinh

Ms. Jessica Trinh

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2020 in The American Journal of Surgery
Verified
Journal Article
Closed access
HCHerbert Chen
Herbert Chen
JTJessica Trinh
Jessica Trinh
GYGeorge P. Yang
George P. Yang

25 March 2019 in Life Science Alliance
Verified
Journal Article
Open access
PDF file
YWYiran Wang
Yiran Wang
CXChongchong Xu
Chongchong Xu
LMLin Ma
Lin Ma
YMYongchao Mou
Yongchao Mou
BZBowen Zhang
Bowen Zhang
XLXue-jun Li
Xue-jun Li
Spinal muscular atrophy (SMA), the leading genetic cause of infant mortality, is caused by reduced levels of functional survival motor neuron (SMN) protein. To identify therapeutic agents for SMA, we established a versatile SMN2-GFP reporter line by targeting the human SMN2 gene. We then screened a compound library and identified Z-FA-FMK as a potent candidate. Z-FA-FMK, a cysteine protease inhibitor, increased functional SMN through inhibiting the protease-mediated degradation of both full-length and exon 7–deleted forms of SMN. Further studies reveal that CAPN1, CAPN7, CTSB, and CTSL mediate the degradation of SMN proteins, providing novel targets for SMA. Notably, Z-FA-FMK mitigated mitochondriopathy and neuropathy in SMA patient–derived motor neurons and showed protective effects in SMA animal model after intracerebroventricular injection. E64d, another cysteine protease inhibitor which can pass through the blood–brain barrier, showed even more potent therapeutic effects after subcutaneous delivery to SMA mice. Taken together, we have successfully established a human SMN2 reporter for future drug discovery and identified the potential therapeutic value of cysteine protease inhibitors in treating SMA via stabilizing SMN proteins.

28 August 2023 in Nature Metabolism
Verified
Journal Article
Closed access
PDF file
EPEmily Perszyk
Emily Perszyk
XDXue S. Davis
Xue S. Davis
JDJelena Djordjevic
Jelena Djordjevic
MJMarilyn Jones-Gotman
Marilyn Jones-Gotman
JTJessica Trinh
Jessica Trinh
DSDana M Small
Dana M Small

23 October 2024 in Nutrients
Verified
Journal Article
Open access
PDF file
MAMopelola A Adeyemo
Mopelola A Adeyemo
JTJessica Trinh
Jessica Trinh
DPDarian Perez
Darian Perez
EBEstabon Bozeman
Estabon Bozeman
ENEjiro Ntekume
Ejiro Ntekume
Alejandra CasillasAlejandra Casillas
Alejandra Casillas
Background: Cardiometabolic disease (CMD) disproportionately affects African American/Black (AA) and Latino communities. CMD disparities are exacerbated by their underrepresentation in clinical trials for CMD treatments including nutritional interventions. The study aimed to (1) form a precision nutrition community consultant panel (PNCCP) representative of Latino and AA communities in Los Angeles to identify barriers and facilitators to recruitment and retention of diverse communities into nutrition clinical trials and (2) develop culturally informed strategies to improve trial diversity. Methods: A deliberative community engagement approach was used to form a PNCCP for the Nutrition for Precision Health (NPH) trial, part of the of the All of Us research initiative. The PNCCP included individuals that provide services for Latino and AA communities who met during 11 virtual sessions over 1 year. Discussion topics included enhancing recruitment and cultural acceptance of the NPH trial. We summarized CCP recommendations by theme using an inductive qualitative approach. Results: The PNCCP included 17 adults (35% AA, 47% Latino). Four thematic recommendations emerged: reducing structural barriers to recruitment, the need for recruitment materials to be culturally tailored and participant-centered, community-engaged trial recruitment, and making nutrition trial procedures inclusive and acceptable. We outlined the study response to feedback, including the constraints that limited implementation of suggestions. Conclusion: This study centers community voices regarding the recruitment and retention of AA and Latino communities into a nutrition clinical trial. It highlights the importance of community engagement early on in protocol development and maintaining flexibility to enhance inclusion of diverse communities in nutrition clinical trials.

28 July 2025 in Eye & Contact Lens: Science & Clinical Practice
Verified
Journal Article
Closed access
JTJessica Trinh
Jessica Trinh
ABAshlie A. Bernhisel
Ashlie A. Bernhisel
CNCherie B. O.D. Nau
Cherie B. O.D. Nau
MSMuriel Schornack
Muriel Schornack
Scleral lenses have been shown to provide improved visual acuity and ocular surface protection in patients with corneal irregularities and ocular surface disease. However, scleral lens (SL) wear may lead to anterior ocular pathology owing to metabolic or mechanical stress. Most reports of SL-related complications have described microbial keratitis or hypoxia-related issues. There is limited literature describing complications caused by mechanical interactions, such as suction between the SL and ocular surface. This case report describes a patient with long-standing keratoconjunctivitis and keratoconus who developed intracorneal hemorrhage within 4 hr of completing application and removal training on the first day of SL wear.